• Home
• Products
  • UV Phototherapy
  • Derma 308
  • MED/MPD Tester
• Order
• FAQ
  • UV Phototherapy
  • Viedo
  • Instruction
  • Real stories
• Membership
• Contact
•  
• KERNEL
  • KERNEL Website
  • Colposcope
  • Photodynamic therapy
  • Patient monitor

Photodynamic therapy for psoriasis.

Choi YM1, Adelzadeh L, Wu JJ.

Author information

Abstract

Abstract Introduction: Photodynamic therapy for psoriasis showed promise in the early 1990s with reports of plaque clearance

following topical aminolevulinic acid - photodynamic therapy (ALA-PDT). Methods: In December 2013, we conducted a systematic 

search of the PubMed Medline database using the keywords "psoriasis" and "photodynamic therapy". Results: Numerous clinical 

studies have failed to demonstrate a consistent, efficacious response to topical ALA-PDT. Furthermore, severe pain and 

burning sensations were repeatedly reported, many cases being intolerable for patients. Discussion: The variability in 

clinical response and the painful side effects have made topical ALA-PDT an unsuitable treatment option for chronic plaque 

psoriasis. Nonetheless, early clinical studies of other modalities such as topical hypericin and methylene blue, as well as 

systemic ALA and verteporfin, have shown that these photosensitizers are efficacious and much better tolerated than topical 

ALA. Conclusion: With the current landscape of phototherapy dominated by psoralen combined with ultraviolet A (PUVA) and 

narrow-band ultraviolet B (NB-UVB), an alternative light therapy utilizing the visible spectrum is certainly promising and a 

worthwhile endeavor to pursue.

KEYWORDS:

ALA; PpIX; aminolevulinic acid; hypericin; methylene blue; verteporfin

www.kerneluvb.com----The leader manufacturer of UV Phototherapy.